In patients with HIV/AIDS, this would include appropriate ART while in post-organ transplant patients this would entail a reduction of immunosuppressive therapy, with certain studies suggesting that switching of immunosuppressive therapy to mTOR inhibitors such as sirolimus improves outcome. This evidence concerns the gene MTOR and AIDS.